Skip to main content
Clinical Trials/ITMCTR2200005548
ITMCTR2200005548Not yet recruiting未知

Clinical observation of TCM combined with low molecular heparin calcium in the treatment of hyperlipidemic acute pancreatitis

The First Affiliated Hospital of Xingtai Medical College (The First Hospital of Xingtai City)0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational study

Eligibility Criteria

Ages
18 to 60 (—)
Sex
All

Inclusion Criteria

  • 1) Meet the diagnostic criteria for hyperlipidemia acute pancreatitis in both traditional Chinese medicine and Western medicine; 2) Abdominal CT and/or MRI meet the diagnostic criteria for pancreatitis; 3) The age of the patient is 20-80 years old; 4) There is no previous history of acute pancreatitis 5) Patients and their families who are fully aware of this study and signed the informed consent form agree to receive traditional Chinese medicine decoction treatment, which will remain unchanged in future treatment.

Exclusion Criteria

  • 1) Exclude acute pancreatitis caused by biliary diseases, alcohol consumption, drugs, tumors, etc.; 2) Chronic pancreatitis such as pancreatic calcification or pancreatic duct calcification and calculi visible on CT and/or MRI imaging; 3) Combined with itself Patients with immune diseases; 4) Patients with mental diseases; 5) Those with severe heart, lung, liver, kidney and other organ insufficiency; 7) Those who are allergic to the selected drugs; 8) Those who have any disease leading to a terminal state.

Investigators

Sponsor
The First Affiliated Hospital of Xingtai Medical College (The First Hospital of Xingtai City)

Similar Trials